3 ·Filed May 11, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
No trading signal. Monitor for subsequent Form 4 filings if Hoeiland acquires shares, which could signal insider conviction.
Final — all horizons settled through T+60d
ALLR ▼ -20.83% at T+60d
NEUTRAL call -20.83% · α vs SPY -25.23% · entry $1.68 → $1.33
T+1d
-9.52%
call -9.52% · α -9.39%
$1.52
settled 6mo ago
T+5d
-14.88%
call -14.88% · α -14.80%
$1.43
settled 5mo ago
T+20d
-4.17%
call -4.17% · α -3.86%
$1.61
settled 5mo ago
T+60d
-20.83%
call -20.83% · α -25.23%
$1.33
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Jesper Hoeiland filed a Form 3 initial statement of beneficial ownership with Allarity Therapeutics, disclosing zero shares owned. This is a routine administrative filing by a new insider with no material financial impact.
Key Facts
- Jesper Hoeiland filed Form 3 on 2026-05-11, reporting zero beneficial ownership in Allarity Therapeutics.
- The filing is an initial statement of ownership, not a transaction or change in position.
- No securities were reported as owned, indicating no current economic exposure to the company.
Financial Impact
No financial impact — zero shares reported.
Risk Factors
- Insider may acquire shares later, but no current position to infer sentiment.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-054429 |
| Document: 0001213900-26-054429-index.html | 0001213900-26-054429 |
| Document: 0001213900-26-054429.txt | 0001213900-26-054429 |
20 reports for ALLR
57% Hit rate @ T+20 Went positive at some point 6 of 7 best @ T+60▲ +38.71%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 8-K | $1.04 | awaiting T+20 | — | $0.9276 (−10.81%) |
Sep 29, 2026 28d ago | 8-K | $0.9651 | awaiting T+20 | — | $0.9276 (−3.89%) |
Sep 28, 2026 29d ago | Press Release | $0.9684 $0.9151 | ▼ −5.50% | ▼ −5.47% | $0.9276 (−4.21%) |
Sep 16, 2026 5w ago | 8-K | $1.16 $0.8699 | ▼ −24.68% | ▼ −27.86% | $0.9276 (−19.69%) |
Sep 14, 2026 6w ago | 8-K | $1.17 $0.8601 | ▼ −26.49% | ▼ −28.75% | $0.9276 (−20.72%) |
Sep 11, 2026 6w ago | Press Release | $1.22 $0.9900 | ▼ −18.85% | ▼ −20.72% | $0.9276 (−23.97%) |
Aug 14, 2026 10w ago | Press Release | $1.37 $1.17 | ▼ −14.60% | ▼ −12.61% | $0.9276 (−32.29%) |
Jul 1, 2026 16w ago | 8-K | $1.33 $1.16 | ▼ −12.78% | ▼ −10.60% | $0.9276 (−30.26%) |
Jun 22, 2026 18w ago | 8-K | $1.36 $1.19 | ▼ −12.50% | ▼ −12.35% | $0.9276 (−31.79%) |
Jun 18, 2026 18w ago | Press Release | $1.43 $1.17 | ▼ −18.18% | ▼ −18.71% | $0.9276 (−35.13%) |
Showing 10 of 20
US Market Status
Market Open — Closes in 2h 35m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers